Artelo Biosciences (ARTL) Current Assets (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Current Assets of $695000.0 for Q4 2025, down 72.82% year-over-year from $2.6 million in Q4 2024, and down 61.96% quarter-over-quarter from $1.8 million in Q3 2025.
Artelo Biosciences (ARTL) Current Assets (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Current Assets for 12 consecutive years, with $695000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 72.82% year-over-year to $695000.0; the TTM figure through Dec 2025 stood at $695000.0 (down 72.82% YoY), while the FY2025 annual figure was $695000.0, down 72.82% from the prior year.
- Current Assets slipped to $695000.0 in Q4 2025 per ARTL's latest filing, from $1.8 million in the prior quarter.
- Across five years, Current Assets topped out at $25.4 million in Q4 2021 and bottomed at $695000.0 in Q4 2025.
- Historically, Current Assets has averaged $11.3 million across 5 years, with a median of $10.6 million in 2021.
- Annual changes were most pronounced in 2021 — Current Assets surged 609.08% — and 2025, when it tumbled 83.12%.
- Artelo Biosciences' Current Assets stood at $25.4 million in 2021, then declined by 27.74% to $18.3 million in 2022, then plunged by 40.07% to $11.0 million in 2023, then tumbled by 76.71% to $2.6 million in 2024, then tumbled by 72.82% to $695000.0 in 2025.
- Business Quant data shows ARTL's Current Assets at $695000.0 in Q4 2025, $1.8 million in Q3 2025, and $2.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - | 695,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 695,000.00 |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Sep 30, 2024 | 4.99 Mn |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Dec 31, 2023 | 10.98 Mn |
| Sep 30, 2023 | 13.43 Mn |
| Jun 30, 2023 | 14.60 Mn |
| Mar 31, 2023 | 16.39 Mn |
| Dec 31, 2022 | 18.32 Mn |
| Sep 30, 2022 | 20.30 Mn |
| Jun 30, 2022 | 22.28 Mn |
| Mar 31, 2022 | 24.59 Mn |
| Nov 30, 2021 | 25.36 Mn |
| Aug 31, 2021 | 10.32 Mn |
| May 31, 2021 | 10.30 Mn |
| Feb 28, 2021 | 11.41 Mn |